IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

GW Pharmaceuticals PLC

CUSIP: 36197T953 | 16 institutional holders

Quarters

Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile